MARATTO

article · AIDS Care

Prevalence and correlates of HIV status disclosure and depressive symptoms among children living with HIV in the central zone of Tanzania

Abstract

The disclosure of Human Immunodeficiency Virus (HIV) status in children remains a sensitive and complex issue in sub-Saharan Africa. This cross-sectional study assessed the prevalence and correlates of HIV status disclosure and depressive symptoms among HIV-infected children. A total of 366 children and their caregivers were recruited from 12 Care and Treatment Centers in Dodoma and Singida regions between June 2021 and December 2022. Data were collected through interviews and analyzed using SPSS v20. The prevalence of HIV status disclosure was 49.7%, and depressive symptoms was 51.1%. Correlates of HIV status disclosure included older child age (AOR = 3.2; 95% CI: 1.3-7.9), longer duration on antiretroviral therapy (ART) (AOR = 7.3; 95% CI: 2.2-24.2), and caregiver prior experience with disclosure (AOR = 0.7; 95% CI: 0.1-0.9). Disclosure was also correlated with increased depressive symptoms (AOR = 1.7; 95% CI: 1.09-3.1). Depressive symptoms were more common among children with male caregivers (AOR = 1.5; 95% CI: 1.1-2.4) and those whose caregivers had prior experience with disclosure (AOR = 2.3; 95% CI: 1.7-4.2). These findings underscore the need to integrate mental health support within HIV care and to enhance male caregiver involvement in child wellbeing.

Research topics

  • HIV/AIDS Research and Interventions
  • Poverty, Education, and Child Welfare
  • Adolescent Sexual and Reproductive Health

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/09540121.2025.2592894

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.